SKN | Invea Therapeutics Sets Terms for $35 Million IPO as Inflammatory Disease Biotech Returns to Public Markets
Inflammatory disease-focused biotech Invea Therapeutics has set the terms for its initial public offering, marking a renewed attempt to access public capital markets after...
SKN | PriceSmart Shares Hold Steady Ahead of Q1 2026 Earnings as Growth Outlook Remains Constructive
PriceSmart, Inc. entered the final trading session ahead of its Q1 2026 earnings report with shares showing limited volatility, signaling a wait-and-see approach from...
SKN | Jefferies Financial Group Shares Climb as Earnings Beat Restores Investor Confidence
Jefferies Financial Group Inc. (NYSE: JEF) closed higher in the latest session as investors reacted positively to a stronger-than-expected earnings performance and improving near-term...
SKN | Penguin Solutions (PENG) Rallies Ahead of Earnings as Profit Momentum and Revenue Stability Support Bullish Sentiment
Penguin Solutions, Inc. (PENG) closed the latest session at $21.07, gaining 3.9 percent, as investors positioned ahead of the company’s upcoming earnings report. The...
SKN | Maxeon Solar Technologies Stock Jumps as Investors Reassess Risk, Turnaround Potential
Market Snapshot and Why It Matters
Shares of Maxeon Solar Technologies surged sharply in the latest session, climbing more than 8% to close near $2.98,...
